In 2025, the oral syringe market was valued at USD 2.47 billion. Based on Future Market Insights' analysis, demand is estimated to grow to USD 2.63 billion in 2026 and USD 4.89 billion by 2036. FMI projects a CAGR of 6.40% during the forecast period.
The market is set to add approximately USD 2.26 billion in absolute terms between 2026 and 2036. Pediatric medication dosing accuracy requirements and medication safety initiatives mandating oral-specific (non-Luer) syringe designs are the primary demand drivers. Hospital patient safety programmes and WHO medication safety recommendations are converting oral liquid medication administration from cup-based estimation to syringe-based precision dosing, with regulatory mandates in the USA and EU requiring non-injectable oral syringe designs to prevent wrong-route administration errors.
As per FMI, country-level growth rates through 2036 are projected as follows: India at 10.50%, China at 9.40%, South Africa at 9.00%, KSA at 7.90%, Japan at 7.50%, Brazil at 7.10%, Mexico at 6.60%, Canada at 6.40%, UK at 5.40%, USA at 5.30%, France at 4.80%, Germany at 4.00%. India records the fastest expansion driven by concentrated industry investment.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 2.63 Billion |
| Industry Value (2036) | USD 4.89 Billion |
| CAGR (2026 to 2036) | 6.40% |
Source: Future Market Insights, 2026
The oral syringe market encompasses needle-free, non-Luer-compatible dosing devices engineered for precise volume measurement and administration of liquid oral medications. Product configurations span small volume (1 to 3 mL), medium volume (5 to 10 mL), and large volume (10 to 60 mL) oral syringes with clear or amber barrels, milliliter graduation markings, and oral-specific tip designs preventing connection to intravenous access lines. FMI is of the opinion that the market is transitioning from a convenience dosing accessory to a patient safety compliance device, driven by ISO 80369-3 connector standards and hospital medication error prevention programmes that mandate dedicated oral-specific syringe designs.
Market scope covers large, medium, and small volume oral syringes sold through prescription and OTC channels for pediatric care, geriatric medication administration, post-surgical and critical care dosing, and dental procedure applications across institutional and retail distribution.
Hypodermic (Luer-compatible) injection syringes, insulin pen devices, pre-filled parenteral syringes, and enteral feeding syringes with ENFit connectors are excluded.
Factors such as the increased number of daycare surgeries, high birth rates, and growing adoption of oral syringes fueled growth of the syringe market. Also, the number of premature neonates in Neonatal Intensive Care Units (NICU) affected the market during 2021 and 2025.
The market is not just growing but also evolving in a sustainable direction. It promotes a circular economy by utilizing eco-friendly and recycled materials and implementing sustainable business models to reduce environmental impact. This commitment to sustainability is not only commendable but also inspiring.
Challenges with Pill Swallowing Fueling Demand
The increasing prevalence of chronic diseases increases the demand for oral syringes. Patients suffering from these diseases need medication management for the long term to control the symptoms and related complications.
Individuals with asthma, diabetes, or hypertension take medication daily, which calls for precise equipment, fueling demand for oral syringes. A dependable method of administering medication in specified amounts is with the help of oral syringes.
Shift towards Home Healthcare Services
The healthcare sector is shifting towards home treatment for health issues. Individuals are getting nursing, medical, and personal care services from professionals in the comfort of their homes. The need for home healthcare services is rising due to the increasing aging population worldwide.
For usage at home, patients require readily available and simple-to-operate gadgets. Disposable oral syringes are a practical tool for self-administration, providing accurate medication dosing and making them the best option for self-care. They are gaining traction among consumers since they are necessary for patient-centered, individualized in-home healthcare.
The below table highlights how large volume syringe segment is leading the market in terms of capacity. It is set to grow at a CAGR of 7.5% through 2034. Based on order type, the OTC (over the counter) segment is projected to record a CAGR of 7.3% through 2036.
| Capacity | Value CAGR |
|---|---|
| Medium Volume Syringe (10 to 20 ml) | 6.0% |
| Large Volume Syringe (Above 20ml) | 7.5% |
Demand for large-volume oral syringes with a capacity above 20 ml is estimated to grow with a CAGR of 7.5%, totaling a market valuation of USD 1,580.1 million by 2036. Large-volume syringes offer convenience to patients with easy and controlled administration of liquid medications. They are prominently used in healthcare facilities for patients of different age groups and medical needs.
| Order Type | Value CAGR |
|---|---|
| OTC (Over the Counter) | 7.3% |
| Prescription | 5.9% |
As per the latest analysis, prescription-based segment is set to dominate the market with a share of 67.4% in 2026. Further, it will grow at a CAGR of 5.9% during the projection period, totaling a valuation of USD 1,955.8 million by 2036.
Oral syringes are widely utilized in prescription-based medicine due to their safety and precise dosing. The healthcare sector's strict regulations are causing several medications to be unavailable without a prescription, increasing the demand for prescription-based syringes.
On the other hand, the OTC segment is anticipated to grow at a higher CAGR of 7.3% during the assessment period. This can be attributed to growing consumer interest in OTC medicines and medical devices due to multiple advantages.
This section will detail the market in key countries, including the United States, Germany, the United Kingdom, Japan, China, and India. It will emphasize the various reasons propelling the growth of oral syringe industry in the countries mentioned below.
.webp "Top Country Growth Comparison Oral Syringe Market Cagr (2026 2036)")
| Countries | Value CAGR (2026 to 2036) |
|---|---|
| United States | 5.3% |
| Canada | 6.4% |
| Brazil | 7.1% |
| Mexico | 6.6% |
| Germany | 4.0% |
| France | 4.8% |
| United Kingdom | 5.4% |
| China | 9.4% |
| India | 10.5% |
| Japan | 7.5% |
| KSA | 7.9% |
| South Africa | 9.0% |
Japan is set to record a CAGR of 7.5% in the assessment year, propelled by an increasing number of elderly citizens, resulting in increased healthcare needs. Japan's oldest population, 1 in 10 people aged 80 or older, necessitates frequent healthcare services.
Oral syringes filled with liquid drugs are a safer and more convenient option for elderly patients who struggle with swallowing pills or tablets. These sophisticated medicine delivery methods are essential for managing chronic illnesses that often affect the elderly, making them a safer and more convenient choice in Japan.
The United States market is projected to advance at a CAGR of 5.3% from 2026 to 2036. This can be attributed to increasing prevalence of chronic illnesses requiring frequent treatment and the need for precise dose distribution, especially in pediatric and geriatric patients.
To correctly deliver liquid drugs in healthcare settings, oral syringes are frequently utilized, especially for patients who have difficulties swallowing tablets or for babies and young children. Thus, a spike in chronic diseases like cardiovascular disease, diabetes, and arthritis will continue to provide impetus for market growth in the United States.
Leading companies in the industry are working on innovative designs to enhance accuracy, convenience, and ease of use. Manufacturing companies are collaborating with pharmaceutical companies to develop syringes for consumer needs. Recent activities and developments implemented by the leading manufacturers and companies in the market.
| Metric | Value |
|---|---|
| Quantitative Units | USD 2.63 Bn to USD 4.89 Bn, at a CAGR of 6.40% |
| Market Definition | Oral syringes are non-Luer-compatible, needle-free dosing devices designed for precise volume measurement and administration of liquid oral medications, available in small, medium, and large volume configurations for pediatric dosing, geriatric medication administration, post-surgical care, and dental procedure applications. |
| Capacity Segmentation | Large Volume Syringe, Medium Volume Syringe, Small Volume Syringe |
| Order Type Segmentation | Prescription, OTC |
| Application Segmentation | Pediatric Care, Geriatric Care, Post-Surgery/Critical Care, Dental Procedures, Others |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
| Countries Covered | India, China, South Africa, KSA, Japan, Brazil, Mexico, Canada, UK, USA, France, Germany, and 40 plus countries |
| Key Companies Profiled | Becton, Dickinson and Company, Adelphi Healthcare Packaging, Schott AG, Gerresheimer AG, West Pharmaceutical Services, Inc., DWK Life Sciences GmbH, Vetter Pharma International GmbH, Comar, LLC, Baxter International Inc., Dentsply Sirona, Terumo Corporation, Merit Medical Systems, Inc., B. Braun Melsungen, Medtronic plc, NIPRO Corporation, Integra LifeSciences |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid bottom-up and top-down modeling validated against primary research inputs and publicly available industry data. |
This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.
How large is the demand for Oral Syringe in the global market in 2026?
Demand for Oral Syringe in the global market is estimated to be valued at USD 2.63 billion in 2026.
What will be the market size of Oral Syringe by 2036?
Market size for Oral Syringe is projected to reach USD 4.89 billion by 2036.
What is the expected demand growth between 2026 and 2036?
Demand is expected to grow at a CAGR of 6.40% between 2026 and 2036.
Which Capacity is poised to lead by 2026?
Large Volume Syringe accounts for 46.8% in 2026.
How significant is Prescription in driving adoption?
Prescription represents 67.4% of segment share in 2026.
What country records the fastest growth?
India is projected to grow at a CAGR of 10.50% during 2026 to 2036.
What is the projected growth for China?
China is projected to expand at a CAGR of 9.40% during 2026 to 2036.
What is included in the scope of this report?
Market scope covers large, medium, and small volume oral syringes sold through prescription and OTC channels for pediatric care, geriatric medication administration, post-surgical and critical care dosing, and dental procedure applications across institutional and retail distribution.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Oral Syringe Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
